Document is current
Any future updates will be listed below
-
Authors
Cattaneo, Stefano
Bettegazzi, Barbara https://orcid.org/0000-0001-5842-105X
Ingusci, Selene https://orcid.org/0000-0002-8534-5942
Verlengia, Gianluca
Anna Sofia, Tascini https://orcid.org/0000-0001-5731-5490
Silvia, Zucchini
Codazzi, Franca
Morelli, Marco J.
Marzulli, Marco
Glorioso, Joseph C. https://orcid.org/0000-0002-1818-2645
Simonato, Michele
-
Funding
Funding for this research was provided by:
EC | EC Seventh Framework Programm | FP7 Health (602102)
- License Information
-
More Information
Article History
Received: 27 February 2025
Revised: 14 August 2025
Accepted: 11 September 2025
First Online: 28 September 2025
Competing interests
: J.C.G. is founder and CSO of Adolore Biotherapeutics, Inc., Senior Advisor of Replay Bio, and consultant of EG247. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. This work was supported by a grant from the European Community (FP7- HEALTH Project 602102 [EPITARGET]).
: The Institutional Animal Care and Use Committee of the San Raffaele Scientific Institute approved the animal use procedures. All methods were performed in accordance with the relevant guidelines and regulations.
